Navigation Links
Cellecta, Inc. Announces Upcoming Presentations at the American Association for Cancer Research 2017 Annual Meeting
Date:3/15/2017

MOUNTAIN VIEW, Calif., March 15, 2017 /PRNewswire/ -- Cellecta, Inc. today announced that it will deliver three scientific presentations at the upcoming American Association for Cancer Research (AACR) 2017 Annual Meeting, which will be take place April 1-5, 2017 at the Walter E. Washington Convention Center in Washington, D.C. Cellecta researchers will present unpublished data on technology developments in genetic screens in human cancer cell lines using CRISPR-knockout, CRISPRi and CRISPRa; as well as new data on applications of the Driver-Map targeted RNA expression solution for profiling immunity biomarkers and cellular composition analysis.

Details of the presentations are as follows:

Poster Abstract 403/ Poster 3: CRISPR/Cas9 genome-wide sgRNA libraries for loss-of-function and gain-of-function genetic screens
Session: Genomic Screening for Cancer Dependencies and Drug Response
Date and Time: Sunday, April 2, 2017, 1:00 - 5:00 p.m. Eastern Time
Location: Convention Center, Halls A-C, Poster Section 17

Spotlight Theatre Presentation: Driver-Map™ Assay: Gene Expression profiling of protein-coding genes for tumor microenvironment analysis and biomarker discovery
Date and Time: Tuesday, April 4, 2017, 10:00 – 11:00 a.m. Eastern Time
Location: Convention Center, Spotlight Theatre B – Hall A

Poster Abstract 4652/ Poster 13: Profiling of immunity biomarkers in whole blood
Session: Diagnostic Biomarkers
Date and Time: Tuesday, April 4, 2017, 1:00 - 5:00 p.m. Eastern Time
Location: Convention Center, Halls A-C, Poster Section 28

About Cellecta:

Cellecta, Inc., a trusted provider of genomic products and services, is an industry leader in RNAi and CRISPR technologies for the discovery and characterization of novel therapeutic targets, and genetic profiling for biomarker discovery. Numerous scientific papers have been published citing Cellecta's functional genomics portfolio offering gene knockout and knockdown screens, custom and genome-wide RNAi and CRISPR libraries, cell engineering, RNAi and CRISPR construct services, and mutation and expression profiling of disease samples.

Cellecta, Inc. is headquartered in Mountain View, California. Further information about the company and its functional genomic products and services may be found online at www.cellecta.com

Cellecta, Inc.

Paul Diehl, 650-938-4050
149887@email4pr.com

Media: Ruth Mercado, 650-938-4080
149887@email4pr.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cellecta-inc-announces-upcoming-presentations-at-the-american-association-for-cancer-research-2017-annual-meeting-300423444.html


'/>"/>
SOURCE Cellecta, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. CELLECTA, INC. Receives NIH SBIR Grant to Develop Validated CRISPR Knockout Library of Guide RNA (sgRNA) Sequences
2. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
3. Annual Conference about Technology Solutions for People with Disabilities Announces Program
4. Probiotic Action Announces Probiotics Lead the Digestive Health Market
5. Verenium Announces Preliminary Financial Results For Fiscal 2012
6. Senomyx Announces Fourth Quarter And Full Year 2012 Financial Results And Initiation Of New Direct Sales Strategy
7. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
8. EAG Announces New General Manager of Release-To-Production (RTP) Division
9. DuPont Tate & Lyle Bio Products Announces Novel Application for Zemea® Propanediol
10. Probiotic Action Announces China’s $5 Billion Dollar Investment in Probiotics
11. EAS Consulting Group, Experts in Quality Regulatory Services Related to FDA Issues, Announces Upcoming Dietary Supplement Seminars in Salt Lake City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer ... hire of Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. ... development activities. , “Dr. Floyd’s career has spanned 30 years in the chemicals ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a ... Biobank and GSK to generate genetic sequence data from the ... will enable researchers to gain valuable insights to support advances ... of serious and life threatening diseases. ... Genetic evidence has revolutionized ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... regeneration from small lab samples to full-size tissues, bones, even whole organs to ... vascular system that delivers blood deep into the developing tissue. , Current ...
(Date:3/22/2017)... 22, 2017  Ascendis Pharma A/S (Nasdaq: ASND), ... technology to address significant unmet medical needs in ... full year ended December 31, 2016. ... company as we broadened our pipeline and pursued ... disease company with an initial focus on endocrinology," ...
Breaking Biology Technology:
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
(Date:3/22/2017)... Calif. , March 21, 2017 ... analytics company serving law enforcement agencies, announced today the ... as director of public safety business development. ... diversified law enforcement experience, including a focus on the ... In his most recent position, Mr. Sheridan served as ...
Breaking Biology News(10 mins):